Astrana Health, Inc. (NASDAQ:ASTH) Receives $65.17 Consensus Target Price from Analysts

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have been assigned an average recommendation of “Buy” from the eight ratings firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $65.17.

A number of research firms have commented on ASTH. Truist Financial boosted their price objective on Astrana Health from $50.00 to $59.00 and gave the stock a “buy” rating in a research note on Friday, August 9th. BTIG Research increased their price objective on shares of Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a report on Thursday, October 3rd. Robert W. Baird boosted their target price on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. KeyCorp assumed coverage on shares of Astrana Health in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Finally, TD Cowen began coverage on shares of Astrana Health in a report on Monday, October 14th. They issued a “buy” rating and a $66.00 price target for the company.

Institutional Trading of Astrana Health

A number of institutional investors have recently bought and sold shares of ASTH. GAMMA Investing LLC acquired a new position in shares of Astrana Health in the 3rd quarter valued at $34,000. Nisa Investment Advisors LLC acquired a new position in Astrana Health in the third quarter valued at about $35,000. KBC Group NV bought a new position in Astrana Health during the third quarter worth about $70,000. Quarry LP acquired a new position in shares of Astrana Health during the 3rd quarter worth about $77,000. Finally, Quest Partners LLC bought a new stake in shares of Astrana Health in the 3rd quarter valued at about $133,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Stock Up 0.9 %

ASTH opened at $42.86 on Friday. Astrana Health has a twelve month low of $32.32 and a twelve month high of $63.20. The firm has a market cap of $2.41 billion, a price-to-earnings ratio of 32.97, a PEG ratio of 1.97 and a beta of 1.24. The firm’s 50-day simple moving average is $53.37 and its 200-day simple moving average is $47.95. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, hitting the consensus estimate of $0.33. The firm had revenue of $478.71 million for the quarter, compared to analysts’ expectations of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. During the same period in the prior year, the firm earned $0.47 earnings per share. Equities research analysts anticipate that Astrana Health will post 1.17 EPS for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.